Market Overview

UPDATE: Morgan Stanley Reiterates On Concord Medical Services Holdings Ltd. On Unsurprising 3Q14


In a report published Tuesday, Morgan Stanley analyst Bin Li reiterated an Underweight rating on Concord Medical Services Holdings Ltd. (NYSE: CCM), but removed the $7.00 price target.

In the report, Morgan Stanley noted, “CCM's 3Q14 non-GAAP EPS of Rmb0.72 beat our estimate by 25%, mainly due to lower G&A expenses caused by the collection of bad debt. Management reiterated 2014 guidance of EPS of US$0.45-0.50 (+25-38% YoY), given the solid operation performance.”

Concord Medical Services Holdings Ltd. closed on Monday at $6.94.

Latest Ratings for CCM

Nov 2012MaintainsOverweight
Jul 2012MaintainsOverweight
Mar 2012MaintainsOverweight

View More Analyst Ratings for CCM
View the Latest Analyst Ratings

Posted-In: Bin Li Morgan StanleyAnalyst Color Price Target Analyst Ratings


Related Articles (CCM)

View Comments and Join the Discussion!

Latest Ratings

AMRXRaymond JamesDowngrades
CATStandpoint ResearchDowngrades
LULUWells FargoMaintains260.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Housing Market Index Beats Expectations

A Look At 3 Top Holdings Of Russian ETFs